Saturn V Capital Management LP Diversified Active

Location: Austin, TX

CIK: 0001964437 · Show all filings

Period: Q4 2025 (← Previous) (Next →)

Filing Date: Feb 17, 2026

Total Value: $545M (100.0% shares, 0.0% debt)

Holdings (20)

ABVX ABIVAX SA 16.1%

Value $87.55M Shares 649,179 Est. Cost $29.41 Unrealized —

AMLX AMYLYX PHARMACEUTICALS INC 10.0%

Value $54.32M Shares 4,496,487 Est. Cost $5.73 Unrealized +137.2%

COGT COGENT BIOSCIENCES INC 7.9%

Value $43.23M Shares 1,217,064 Est. Cost $7.59 Unrealized +270.2%

JAZZ JAZZ PHARMACEUTICALS PLC 7.7%

Value $42.17M Shares 248,070 Est. Cost $112.15 Unrealized +36.7%

PCVX VAXCYTE INC 6.8%

Value $36.86M Shares 798,940 Est. Cost $43.98 Unrealized +1.7%

DYN DYNE THERAPEUTICS INC 6.4%

Value $34.99M Shares 1,788,616 Est. Cost $11.19 Unrealized +69.2%

PHVS PHARVARIS N V 5.8%

Value $31.64M Shares 1,140,033 Est. Cost $22.60 Unrealized +6.6%

CELC CELCUITY INC 5.8%

Value $31.63M Shares 317,095 Est. Cost $15.84 Unrealized +418.9%

ALMS ALUMIS INC 5.6%

Value $30.61M Shares 3,135,953 Est. Cost $6.98 Unrealized 0.0%

IRON DISC MEDICINE INC 4.3%

Value $23.7M Shares 298,429 Est. Cost $47.97 Unrealized +76.1%

XFOR X4 PHARMACEUTICALS INC 4.3%

Value $23.2M Shares 5,800,530 Est. Cost $3.63 Unrealized 0.0%

MNPR MONOPAR THERAPEUTICS INC 3.9%

Value $21.27M Shares 325,701 Est. Cost $64.05 Unrealized +27.6%

IVVD INVIVYD INC 3.5%

Value $19.11M Shares 7,735,386 Est. Cost $2.08 Unrealized 0.0%

OCUL OCULAR THERAPEUTIX INC 3.4%

Value $18.27M Shares 1,504,880 Est. Cost $10.21 Unrealized +19.0%

IMMX IMMIX BIOPHARMA INC 2.9%

Value $15.69M Shares 2,999,169 Est. Cost $4.12 Unrealized 0.0%

OCS OCULIS HOLDING AG 1.9%

Value $10.32M Shares 516,761 Est. Cost $20.00 Unrealized 0.0%

IKT INHIBIKASE THERAPEUTICS INC 1.5%

Value $7.906M Shares 3,856,799 Est. Cost $1.59 Unrealized 0.0%

CNTA CENTESSA PHARMACEUTICALS PLC 1.3%

Value $7.07M Shares 282,692 Est. Cost $13.84 Unrealized —

OVID OVID THERAPEUTICS INC 0.7%

Value $4.075M Shares 2,500,000 Est. Cost $1.54 Unrealized 0.0%

IVA INVENTIVA SA 0.2%

Value $1.317M Shares 283,166 Est. Cost $4.65 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ABVX	ABIVAX SA	649,179	$87.55M	16.1%	$29.41	—	SPONSORED ADS	00370M103
AMLX	AMYLYX PHARMACEUTICALS INC	4,496,487	$54.32M	10.0%	$5.73	+137.2%	COM	03237H101
COGT	COGENT BIOSCIENCES INC	1,217,064	$43.23M	7.9%	$7.59	+270.2%	COM	19240Q201
JAZZ	JAZZ PHARMACEUTICALS PLC	248,070	$42.17M	7.7%	$112.15	+36.7%	SHS USD	G50871105
PCVX	VAXCYTE INC	798,940	$36.86M	6.8%	$43.98	+1.7%	COM	92243G108
DYN	DYNE THERAPEUTICS INC	1,788,616	$34.99M	6.4%	$11.19	+69.2%	COM	26818M108
PHVS	PHARVARIS N V	1,140,033	$31.64M	5.8%	$22.60	+6.6%	COM	N69605108
CELC	CELCUITY INC	317,095	$31.63M	5.8%	$15.84	+418.9%	COM	15102K100
ALMS	ALUMIS INC	3,135,953	$30.61M	5.6%	$6.98	0.0%	COM	022307102
IRON	DISC MEDICINE INC	298,429	$23.7M	4.3%	$47.97	+76.1%	COM	254604101
XFOR	X4 PHARMACEUTICALS INC	5,800,530	$23.2M	4.3%	$3.63	0.0%	COM NEW	98420X202
MNPR	MONOPAR THERAPEUTICS INC	325,701	$21.27M	3.9%	$64.05	+27.6%	COM NEW	61023L207
IVVD	INVIVYD INC	7,735,386	$19.11M	3.5%	$2.08	0.0%	COM	00534A102
OCUL	OCULAR THERAPEUTIX INC	1,504,880	$18.27M	3.4%	$10.21	+19.0%	COM	67576A100
IMMX	IMMIX BIOPHARMA INC	2,999,169	$15.69M	2.9%	$4.12	0.0%	COM	45258H106
OCS	OCULIS HOLDING AG	516,761	$10.32M	1.9%	$20.00	0.0%	ORDINARY SHARES	H5870P102
IKT	INHIBIKASE THERAPEUTICS INC	3,856,799	$7.906M	1.5%	$1.59	0.0%	COM NEW	45719W205
CNTA	CENTESSA PHARMACEUTICALS PLC	282,692	$7.07M	1.3%	$13.84	—	SPONSORED ADS	152309100
OVID	OVID THERAPEUTICS INC	2,500,000	$4.075M	0.7%	$1.54	0.0%	COM	690469101
IVA	INVENTIVA SA	283,166	$1.317M	0.2%	$4.65	—	ADS	46124U107